Manufacturers Life Insurance Company, The Terns Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 66,100 shares of TERN stock, worth $387,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,100
Previous 22,645
191.9%
Holding current value
$387,346
Previous $154,000
257.79%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TERN
# of Institutions
167Shares Held
78.3MCall Options Held
580KPut Options Held
454K-
Orbimed Advisors LLC San Diego, CA7.56MShares$44.3 Million1.49% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$40.4 Million8.42% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.22MShares$36.5 Million4.41% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$32.7 Million1.71% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$24.1 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $220M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...